Capsule (CPS) |
Antimicrobial resistance, host–pathogen interactions and pathogenesis |
Efflux pumps |
Antimicrobial resistance, biofilm formation, disinfectant resistance, heavy metal resistance and response to oxidative and osmotic stresses |
Lipopolysaccharide (LPS) |
Antimicrobial resistance, bacterial motility and induction of pro-inflammatory cytokines in humans |
Lipooligosaccharide (LOS) |
Antimicrobial resistance, bacterial adhesion, resistance to human opsono-phagocytosis and induction of pro-inflammatory cytokines in humans |
Outer membrane proteins (OMPs) |
Antimicrobial resistance, induction of apoptosis in human cells, bacterial adhesion, invasion and dissemination, cytotoxicity in human cells, host–pathogen interactions, induction of reactive oxygen species (ROS) in human cells, metal ion acquisition and substrate translocation |
Pili |
Bacterial adhesion, bacterial attachment (irreversible), biofilm formation, genetic exchange through HGT and motility (e.g., twitching) |
Metal ion uptake systems |
Bacterial metal (e.g., Zn, Fe, Mn) uptake, translocation, metabolism homeostasis, biofilm formation, quorum sensing regulation and response to oxidative stress |
Two-component systems (TCSs) |
Antimicrobial resistance, aromatic compound metabolism, bacterial pathogenesis, biofilm formation, capsule expression, regulation of bacterial motility, lipid A modification, regulation of some groups of efflux pumps and resistance to human serum |
Secretion systems (SSs) |
Antimicrobial resistance, bacterial adhesion, biofilm formation, bacterial colonization and proliferation within the human cells, bacterial survival, enzyme and toxin secretion, induction of apoptosis in human cells, genetic elements exchange via HGT and pathogenesis |